跳到正文
TechCrunch·· 4 天前AI 评分25

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

Intero Biosystems wants drugmakers to test on mini human intestines, not animals

利好+0.35对 相关行业影响 中等

监管推动动物试验替代方案,利好类器官需求

stock_ai_django 新闻打标(gpt-6-luna),方向针对资产价格,不是本站判断,也不构成投资建议

AI 导读

Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.

来源:TechCrunch · techcrunch.com